Published in J Biol Chem on August 25, 1990
Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes. Microbiol Rev (1993) 3.33
In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease. Proc Natl Acad Sci U S A (1993) 2.16
Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease. J Virol (2002) 1.71
Antiviral therapy for human immunodeficiency virus infections. Clin Microbiol Rev (1995) 1.49
Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy. J Clin Microbiol (2000) 1.35
Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitors. Antimicrob Agents Chemother (2006) 1.25
Antiretroviral drug resistance in human immunodeficiency virus type 2. Antimicrob Agents Chemother (2009) 1.17
Polymorphism and drug-selected mutations in the protease gene of human immunodeficiency virus type 2 from patients living in Southern France. J Clin Microbiol (2004) 1.15
Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants. J Clin Microbiol (2009) 1.12
The eukaryotic translation initiation factor 4GI is cleaved by different retroviral proteases. J Virol (2003) 1.06
Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro. Biochem J (1996) 1.02
In vitro anti-human immunodeficiency virus (HIV) activity of XM323, a novel HIV protease inhibitor. Antimicrob Agents Chemother (1993) 1.00
Human immunodeficiency virus type-1 reverse transcriptase and ribonuclease H as substrates of the viral protease. Protein Sci (1993) 0.99
Effects of U-75875, a peptidomimetic inhibitor of retroviral proteases, on simian immunodeficiency virus infection in rhesus monkeys. Antimicrob Agents Chemother (1994) 0.88
Solvent accessibility as a predictive tool for the free energy of inhibitor binding to the HIV-1 protease. Protein Sci (1995) 0.87
Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures. Proc Natl Acad Sci U S A (1993) 0.85
Comparative studies on retroviral proteases: substrate specificity. Viruses (2010) 0.85
Human immunodeficiency virus type 1 and type 2 protease monomers are functionally interchangeable in the dimeric enzymes. J Virol (1992) 0.83
A mean field model of ligand-protein interactions: implications for the structural assessment of human immunodeficiency virus type 1 protease complexes and receptor-specific binding. Proc Natl Acad Sci U S A (1996) 0.82
Toxins that are activated by HIV type-1 protease through removal of a signal for degradation by the N-end-rule pathway. Biochem J (1999) 0.79
Molecular modeling studies suggest that zinc ions inhibit HIV-1 protease by binding at catalytic aspartates. Environ Health Perspect (1993) 0.76
Four Amino Acid Changes in HIV-2 Protease Confer Class-Wide Sensitivity to Protease Inhibitors. J Virol (2015) 0.75
Amino acid analysis by reverse-phase high-performance liquid chromatography: precolumn derivatization with phenylisothiocyanate. Anal Biochem (1984) 5.85
Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature (1999) 5.48
Structural basis of substrate specificity in the serine proteases. Protein Sci (1995) 4.22
Amino acid sequence of human platelet factor 4. Proc Natl Acad Sci U S A (1977) 4.04
Redesigning trypsin: alteration of substrate specificity. Science (1985) 3.70
Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem (1993) 3.52
Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. Proc Natl Acad Sci U S A (2000) 3.06
Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci U S A (1981) 3.03
Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity. Proc Natl Acad Sci U S A (1987) 2.99
Naegleria and Acanthamoeba infections: review. Rev Infect Dis (1990) 2.92
A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation. Science (1990) 2.80
4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. Proc Natl Acad Sci U S A (1980) 2.80
Splice junctions: association with variation in protein structure. Science (1983) 2.54
Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem (2000) 2.50
Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin. Nat Biotechnol (2000) 2.49
Structure of two related rat pancreatic trypsin genes. J Biol Chem (1984) 2.24
Evolutionary divergence of substrate specificity within the chymotrypsin-like serine protease fold. J Biol Chem (1997) 2.05
Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. Proc Natl Acad Sci U S A (1999) 2.01
Cation binding to the integrin CD11b I domain and activation model assessment. Structure (1998) 1.90
The catalytic role of the active site aspartic acid in serine proteases. Science (1987) 1.88
Leptomyxid ameba, a new agent of amebic meningoencephalitis in humans and animals. J Clin Microbiol (1990) 1.88
The three-dimensional structure of Asn102 mutant of trypsin: role of Asp102 in serine protease catalysis. Science (1987) 1.87
Substrate specificity of the protein tyrosine phosphatases. Proc Natl Acad Sci U S A (1993) 1.84
Amino acid sequence of phospholipase A2-alpha from the venom of Crotalus adamanteus. A new classification of phospholipases A2 based upon structural determinants. J Biol Chem (1977) 1.81
Regulation of clathrin assembly and trimerization defined using recombinant triskelion hubs. Cell (1995) 1.80
Nucleotide sequence and expression of the capsid protein gene of feline calicivirus. J Virol (1991) 1.78
Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity. J Virol (1995) 1.78
Molecular cloning and primary structure of human 15-lipoxygenase. Biochem Biophys Res Commun (1988) 1.76
Domain flexibility in retroviral proteases: structural implications for drug resistant mutations. Biochemistry (1998) 1.75
alpha-Melanotropin: the minimal active sequence in the frog skin bioassay. J Med Chem (1987) 1.75
Calpain 2 and Src dependence distinguishes mesenchymal and amoeboid modes of tumour cell invasion: a link to integrin function. Oncogene (2006) 1.73
Regulation of autoproteolysis of the HIV-1 and HIV-2 proteases with engineered amino acid substitutions. J Biol Chem (1993) 1.70
Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases. Br J Cancer (2006) 1.67
Definition and redesign of the extended substrate specificity of granzyme B. J Biol Chem (1998) 1.65
Intron-exon splice junctions map at protein surfaces. Nature (1982) 1.65
Characterization of globin domains: heme binding to the central exon product. Proc Natl Acad Sci U S A (1980) 1.63
The Hsp56 component of steroid receptor complexes binds to immobilized FK506 and shows homology to FKBP-12 and FKBP-13. J Biol Chem (1992) 1.63
Isolation and sequence of a rat chymotrypsin B gene. J Biol Chem (1984) 1.61
A cumulative specificity model for proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data base. J Biol Chem (1991) 1.59
The HIV-1 protease as enzyme and substrate: mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties. Biochemistry (1994) 1.59
The sequence, organization, and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi. J Biol Chem (1992) 1.58
Characterization of an axenic strain of Hartmannella vermiformis obtained from an investigation of nosocomial legionellosis. J Protozool (1991) 1.56
Effect of point mutations on the kinetics and the inhibition of human immunodeficiency virus type 1 protease: relationship to drug resistance. Biochemistry (1995) 1.56
Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. Proc Natl Acad Sci U S A (1990) 1.55
The atomic-resolution structure of human caspase-8, a key activator of apoptosis. Structure (1999) 1.54
Evolution of phosphofructokinase--gene duplication and creation of new effector sites. Nature (1984) 1.52
A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation. Nat Cell Biol (2001) 1.51
The exocrine protein trypsinogen is targeted into the secretory granules of an endocrine cell line: studies by gene transfer. J Cell Biol (1985) 1.50
Introduction of a cysteine protease active site into trypsin. Biochemistry (1989) 1.50
The crystal structure of cruzain: a therapeutic target for Chagas' disease. J Mol Biol (1995) 1.49
Selective alteration of substrate specificity by replacement of aspartic acid-189 with lysine in the binding pocket of trypsin. Biochemistry (1987) 1.48
Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor. Biochemistry (1991) 1.48
Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease. Proc Natl Acad Sci U S A (1990) 1.46
A primary determinant for lipoxygenase positional specificity. Nature (1991) 1.45
Structure of the two related elastase genes expressed in the rat pancreas. J Biol Chem (1984) 1.43
The selective S-methylation of sulfhydryl groups in proteins and peptides with methyl-p-nitrobenzenesulfonate. J Biol Chem (1971) 1.41
Two approaches to discovering and developing new drugs for Chagas disease. Mem Inst Oswaldo Cruz (2009) 1.41
The covalent and tertiary structure of bovine liver rhodanese. Nature (1978) 1.41
A new class of phospholipases A2 with lysine in place of aspartate 49. Functional consequences for calcium and substrate binding. J Biol Chem (1984) 1.38
Immunologic and proteolytic analysis of HIV-1 reverse transcriptase structure. Virology (1990) 1.38
Complete amino acid sequence of pig kidney fructose-1,6-bisphosphatase. Proc Natl Acad Sci U S A (1982) 1.37
Sequence of the bacteriophage SP01 gene coding for transcription factor 1, a viral homologue of the bacterial type II DNA-binding proteins. Proc Natl Acad Sci U S A (1984) 1.36
Alpha-melanotropin: the minimal active sequence in the lizard skin bioassay. Gen Comp Endocrinol (1989) 1.34
Proteases from human immunodeficiency virus and avian myeloblastosis virus show distinct specificities in hydrolysis of multidomain protein substrates. J Virol (1990) 1.33
Amino acid sequence and characterization of a protein inhibitor of protein kinase C. J Biol Chem (1990) 1.32
Protein tyrosine phosphatase substrate specificity: size and phosphotyrosine positioning requirements in peptide substrates. Biochemistry (1994) 1.32
Dissociative inhibition of dimeric enzymes. Kinetic characterization of the inhibition of HIV-1 protease by its COOH-terminal tetrapeptide. J Biol Chem (1991) 1.29
Substrate specificity of trypsin investigated by using a genetic selection. Proc Natl Acad Sci U S A (1990) 1.29
Pathogenic amoebas from brackish and ocean sediments, with a description of Acanthamoeba hatchetti, n. sp. Science (1977) 1.28
Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease. Biochemistry (1990) 1.26
Production of crystallizable cruzain, the major cysteine protease from Trypanosoma cruzi. J Biol Chem (1993) 1.26
Site-directed mutagenesis shows that tyrosine 248 of carboxypeptidase A does not play a crucial role in catalysis. Nature (1985) 1.25
Structure-based design of HIV protease inhibitors: sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors. J Med Chem (1996) 1.24
Active site cysteinyl and arginyl residues of rhodanese. A novel formation of disulfide bonds in the active site promoted by phenylglyoxal. J Biol Chem (1978) 1.24
Viral proteases: evolution of diverse structural motifs to optimize function. Cell (1997) 1.24
Gene duplication in the evolution of the two complementing domains of gram-negative bacterial tetracycline efflux proteins. Gene (1990) 1.24
Structural determinants of specificity in the cysteine protease cruzain. Protein Sci (1997) 1.24
Amplification and sequencing of genomic DNA fragments encoding cysteine proteases from protozoan parasites. Mol Biochem Parasitol (1990) 1.23
Perturbing the polar environment of Asp102 in trypsin: consequences of replacing conserved Ser214. Biochemistry (1992) 1.22
Applications of thermolysin in protein structural analysis. Methods Enzymol (1977) 1.22
Isolation and characterization of a cDNA encoding rat cationic trypsinogen. Biochemistry (1987) 1.22
Expression of cloned human reticulocyte 15-lipoxygenase and immunological evidence that 15-lipoxygenases of different cell types are related. J Biol Chem (1990) 1.21
The covalent protein structure of insecticyanin, a blue biliprotein from the hemolymph of the tobacco hornworm, Manduca sexta L. J Biol Chem (1984) 1.21
Predicting human immunodeficiency virus protease cleavage sites in proteins by a discriminant function method. Proteins (1996) 1.20